Work

Soluble B-cell maturation antigen as a biomarker of progression and treatment response in patients with myeloma precursors

Year: 2026

Type: article

Source: Blood Neoplasia

DOI: 10.1016/j.bneo.2026.100284

Authors: Wei Tan, Jianliang Dai, Chutima Kunacheewa, Melody R. Becnel, Hans C. Lee, Krina K. Patel, David A. Berrios Nolasco, Mei Huang, Amishi U. Vora, Sheeba K. Thomas, Oren Pasvolsky, Zuzana Lutter-Berka, Isere Kuiatse, Neha S. Korde, Sundar Jagannath, Ola Landgren, Suyu Liu, Elisabet E. Manasanch, Robert Z. Orlowski

Institutions: The University of Texas MD Anderson Cancer Center, Siriraj Hospital, Mahidol University, Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, University of Miami, Sylvester Comprehensive Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

Funders: Leukemia and Lymphoma Society, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Paula and Rodger Riney Foundation, University of Texas MD Anderson Cancer Center, National Cancer Institute

Awards: G2674721518, G293715275, Cancer Center Support Grant

OpenAlex ID: W7202160810

FWCI:

Cites: 21

Cited by:

Related to: 10